Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
Klein-Scory S, Baraniskin A, Schmiegel W, Mika T, Schroers R, Held S, Heinrich K, Tougeron D, Modest DP, Schwaner I, Eucker J, Pihusch R, Stauch M, Kaiser F, Kahl C, Karthaus M, Müller C, Burkart C, Stintzing S, Heinemann V.
Klein-Scory S, et al. Among authors: baraniskin a.
Mol Oncol. 2024 Dec 4. doi: 10.1002/1878-0261.13778. Online ahead of print.
Mol Oncol. 2024.
PMID: 39630848
Free article.